表紙：バイオ機械市場の2030年までの予測：タイプ別、モータータイプ別、用途別、地域別の世界分析

市場調査レポート

商品コード

1372037

バイオ機械市場の2030年までの予測：タイプ別、モータータイプ別、用途別、地域別の世界分析

Biological Machines Market Forecasts to 2030 - Global Analysis By Type (Myosin, Dynein, Kinesin, Ribosomes and Other Types), Motor Type, Application and By Geography

出版日: 2023年10月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,150 605,651円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 766,185円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 926,719円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,094,550円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=145.94円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、世界の生物学的機械市場は2023年に46億米ドルを占め、予測期間中にCAGR 38.4％で成長し、2030年には453億米ドルに達する見込みです。

バイオマシンとも呼ばれる生物学的機械は、細胞、タンパク質、遺伝物質などの生物学的要素から設計の着想を得たり、生物学的要素で作られている洗練されたシステムやガジェットです。これらは、特定の仕事や機能を実行することを目的としています。これらの装置は、産業用、科学用、医療用などさまざまな用途のために、生物の能力を複製したり利用したりするように設計されていることが多いです。これらのデバイスは、多くの分野を変革し、生物学とテクノロジーに関する知識を進歩させる力を持っています。

既存の生物学的システムとの統合

現在の生物学的機能とスムーズに連動する生物学的デバイスを作ることは可能です。有機的な生物学的プロセスの正確さと有効性を利用するのです。人体内の特定の細胞や組織に焦点を当てることで、薬剤の投与や、より正確な業務の遂行に用いられます。生物学的成分と合成成分を組み合わせることで、改善された、あるいは新しい機能を持つハイブリッド・デバイスを作り出すことができます。これらは、完全に合成された代替品よりも、より効果的なバイオセンサー、バイオアクチュエータ、バイオ燃料電池となりうる。これらが市場拡大の原動力となっています。

限られた制御と予測可能性

生物学的システムはもともと複雑で変化しやすいです。生物学的機械の挙動は、遺伝学、環境、細胞反応などの幅広い変数に依存するため、予測や制御が困難な場合があります。さらに、生物学的構成要素は時間とともに劣化する可能性があり、寿命は有限です。このため、従来の機械システムと比べて、生物学的機械の長期的な有用性や信頼性が制限され、市場の拡大が制限されています。

廃棄物の削減

従来の工業的手法と比較すると、生物学的システムは廃棄物や有害な製品別の発生が少ないことが多く、環境に優しいです。医薬品、バイオ燃料、化学薬品など、さまざまな製品を製造するために、こうした生物学的機械は、バクテリア、酵母、藻類などの生物を使用することが多いです。これらは原材料を目的の製品に変えるのに非常に効果的であるため、廃棄物の発生が少ないです。その結果、廃棄物処理費用が削減され、生産方法がよりクリーンなものになる可能性があります。これが市場拡大に影響を与えている要素です。

安全性と封じ込め

生物学的機械は、封じ込めや安全性の面で危険です。遺伝子組み換え生物が誤って放出される可能性があり、生態系に予期せぬ影響を及ぼすかもしれないです。さらに、これらの装置が必ずしも意図したほどエネルギー効率が高いとは限らない可能性もあります。生物学的システムは、細胞レベルではもともとエネルギー効率に優れているが、機械に組み込まれた場合、これらのコンポーネントの維持・管理に必要なエネルギーは相当なものになる可能性があります。これらは市場のさらなる拡大を阻む要素です。

COVID-19の影響：

COVID-19以降、物流に厳しいルールが設けられ、貿易ルートが遮断されました。ある場所から別の場所への製品の輸送は、サプライチェーンと物流部門に対する規制によって妨げられました。しかし、流行中の渡航禁止と国境閉鎖によって輸入品がなくなった結果、地元のミードの売上は増加しました。さらに、パブやレストランが長期間休業したため、顧客は飲酒習慣を変えざるを得なかっています。缶入りワインのような人気のある飲み物は、この傾向が続くと予想されます。

予測期間中、ミオシン・セグメントが最大になると予想される

予測期間中、ミオシン・セグメントが最大になると予想されます。ミオシンと呼ばれるタンパク質は、筋肉の収縮を含む多くの生物学的機能に不可欠です。ミオシン駆動の分子モーターを説明するために使われる「生物学的機械」という言葉には、複数の利点があります。化学エネルギー（ATP）を利用して機械的な力と運動を生み出すことで、分子モーターとして機能します。アクチンフィラメントに沿って"歩く"と、アクチンフィラメントが互いに移動し、筋収縮やその他多くの細胞機能を引き起こします。

予測期間中にCAGRが最も高くなると予想されるのは機械学習セグメントです。

予測期間中、CAGRが最も高くなると予想されるのは機械学習セグメントです。一般に生物学的機械と呼ばれるバイオハイブリッドシステムは、機械学習を使用する際に様々な利点をもたらします。これらのシステムは、センサーや制御装置のような人工的な要素と、細胞や生物のような生物学的な要素を混ぜ合わせ、柔軟で適応性のあるシステムを提供します。これらのシステムは、変化する環境状況やニーズに適応するアルゴリズムの能力により、様々な刺激に動的に反応します。

最大のシェアを占める地域

予測期間中、北米が最大の市場シェアを占めると予測されています。この地域には、遺伝子工学、細胞治療、創薬など、さまざまな用途の生物学的機械の創造に努めるバイオテクノロジー企業が複数存在します。この地域の大学や研究施設は、生物学的機械に関連する分野で最先端の研究を行っています。この分野を発展させるために、彼らはビジネス・パートナーや政府機関と頻繁に協力しています。

CAGRが最も高い地域：

予測期間中、CAGRが最も高いのはアジア太平洋地域です。合成生物学の研究は、この地域の国々で活発に行われています。この分野では、バイオ燃料の生成、医薬品、環境浄化など、さまざまな用途のために生物学的システム、装置、部品が設計・構築されます。医療に使用するための生物学的デバイスの作成は、世界の取り組みです。これには、組織工学、人工臓器の製造、医療機器用の生物活性材料の製造などが含まれます。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

企業プロファイル
- 追加市場プレーヤーの包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋地域
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋地域
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東とアフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東とアフリカ

第9章主な発展

契約、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品の発売
事業拡大
その他の主要戦略

第10章企業プロファイル

Ginkgo Bioworks
Zymergen
Synthace
Codexis
Twist Bioscience
Evonetix
Arzeda
Synthorx
Amyris
Novozymes
Desktop Genetics
Synlogic
Molecular Machines & Industries

図表

List of Tables

Table 1 Global Biological Machines Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Biological Machines Market Outlook, By Type (2021-2030) ($MN)
Table 3 Global Biological Machines Market Outlook, By Myosin (2021-2030) ($MN)
Table 4 Global Biological Machines Market Outlook, By Dynein (2021-2030) ($MN)
Table 5 Global Biological Machines Market Outlook, By Kinesin (2021-2030) ($MN)
Table 6 Global Biological Machines Market Outlook, By Ribosomes (2021-2030) ($MN)
Table 7 Global Biological Machines Market Outlook, By Other Types (2021-2030) ($MN)
Table 8 Global Biological Machines Market Outlook, By Motor Type (2021-2030) ($MN)
Table 9 Global Biological Machines Market Outlook, By Linear (2021-2030) ($MN)
Table 10 Global Biological Machines Market Outlook, By Flagella Movement (2021-2030) ($MN)
Table 11 Global Biological Machines Market Outlook, By Muscle Contraction (2021-2030) ($MN)
Table 12 Global Biological Machines Market Outlook, By Rotary (2021-2030) ($MN)
Table 13 Global Biological Machines Market Outlook, By Adenosine Triphosphate(ATP) Hydrolysis (2021-2030) ($MN)
Table 14 Global Biological Machines Market Outlook, By Bacterial Flagellar (2021-2030) ($MN)
Table 15 Global Biological Machines Market Outlook, By Deoxyribonucleic Acid (DNA) Helicases (2021-2030) ($MN)
Table 16 Global Biological Machines Market Outlook, By Other Motor Types (2021-2030) ($MN)
Table 17 Global Biological Machines Market Outlook, By Application (2021-2030) ($MN)
Table 18 Global Biological Machines Market Outlook, By Biomedical Devices (2021-2030) ($MN)
Table 19 Global Biological Machines Market Outlook, By Machine Learning (2021-2030) ($MN)
Table 20 Global Biological Machines Market Outlook, By Biotechnology (2021-2030) ($MN)
Table 21 Global Biological Machines Market Outlook, By Artificial Intelligence (2021-2030) ($MN)
Table 22 Global Biological Machines Market Outlook, By Biofuel Production (2021-2030) ($MN)
Table 23 Global Biological Machines Market Outlook, By Nanotechnology (2021-2030) ($MN)
Table 24 Global Biological Machines Market Outlook, By Robotics (2021-2030) ($MN)
Table 25 Global Biological Machines Market Outlook, By Other Applications (2021-2030) ($MN)
Table 26 North America Biological Machines Market Outlook, By Country (2021-2030) ($MN)
Table 27 North America Biological Machines Market Outlook, By Type (2021-2030) ($MN)
Table 28 North America Biological Machines Market Outlook, By Myosin (2021-2030) ($MN)
Table 29 North America Biological Machines Market Outlook, By Dynein (2021-2030) ($MN)
Table 30 North America Biological Machines Market Outlook, By Kinesin (2021-2030) ($MN)
Table 31 North America Biological Machines Market Outlook, By Ribosomes (2021-2030) ($MN)
Table 32 North America Biological Machines Market Outlook, By Other Types (2021-2030) ($MN)
Table 33 North America Biological Machines Market Outlook, By Motor Type (2021-2030) ($MN)
Table 34 North America Biological Machines Market Outlook, By Linear (2021-2030) ($MN)
Table 35 North America Biological Machines Market Outlook, By Flagella Movement (2021-2030) ($MN)
Table 36 North America Biological Machines Market Outlook, By Muscle Contraction (2021-2030) ($MN)
Table 37 North America Biological Machines Market Outlook, By Rotary (2021-2030) ($MN)
Table 38 North America Biological Machines Market Outlook, By Adenosine Triphosphate(ATP) Hydrolysis (2021-2030) ($MN)
Table 39 North America Biological Machines Market Outlook, By Bacterial Flagellar (2021-2030) ($MN)
Table 40 North America Biological Machines Market Outlook, By Deoxyribonucleic Acid (DNA) Helicases (2021-2030) ($MN)
Table 41 North America Biological Machines Market Outlook, By Other Motor Types (2021-2030) ($MN)
Table 42 North America Biological Machines Market Outlook, By Application (2021-2030) ($MN)
Table 43 North America Biological Machines Market Outlook, By Biomedical Devices (2021-2030) ($MN)
Table 44 North America Biological Machines Market Outlook, By Machine Learning (2021-2030) ($MN)
Table 45 North America Biological Machines Market Outlook, By Biotechnology (2021-2030) ($MN)
Table 46 North America Biological Machines Market Outlook, By Artificial Intelligence (2021-2030) ($MN)
Table 47 North America Biological Machines Market Outlook, By Biofuel Production (2021-2030) ($MN)
Table 48 North America Biological Machines Market Outlook, By Nanotechnology (2021-2030) ($MN)
Table 49 North America Biological Machines Market Outlook, By Robotics (2021-2030) ($MN)
Table 50 North America Biological Machines Market Outlook, By Other Applications (2021-2030) ($MN)
Table 51 Europe Biological Machines Market Outlook, By Country (2021-2030) ($MN)
Table 52 Europe Biological Machines Market Outlook, By Type (2021-2030) ($MN)
Table 53 Europe Biological Machines Market Outlook, By Myosin (2021-2030) ($MN)
Table 54 Europe Biological Machines Market Outlook, By Dynein (2021-2030) ($MN)
Table 55 Europe Biological Machines Market Outlook, By Kinesin (2021-2030) ($MN)
Table 56 Europe Biological Machines Market Outlook, By Ribosomes (2021-2030) ($MN)
Table 57 Europe Biological Machines Market Outlook, By Other Types (2021-2030) ($MN)
Table 58 Europe Biological Machines Market Outlook, By Motor Type (2021-2030) ($MN)
Table 59 Europe Biological Machines Market Outlook, By Linear (2021-2030) ($MN)
Table 60 Europe Biological Machines Market Outlook, By Flagella Movement (2021-2030) ($MN)
Table 61 Europe Biological Machines Market Outlook, By Muscle Contraction (2021-2030) ($MN)
Table 62 Europe Biological Machines Market Outlook, By Rotary (2021-2030) ($MN)
Table 63 Europe Biological Machines Market Outlook, By Adenosine Triphosphate(ATP) Hydrolysis (2021-2030) ($MN)
Table 64 Europe Biological Machines Market Outlook, By Bacterial Flagellar (2021-2030) ($MN)
Table 65 Europe Biological Machines Market Outlook, By Deoxyribonucleic Acid (DNA) Helicases (2021-2030) ($MN)
Table 66 Europe Biological Machines Market Outlook, By Other Motor Types (2021-2030) ($MN)
Table 67 Europe Biological Machines Market Outlook, By Application (2021-2030) ($MN)
Table 68 Europe Biological Machines Market Outlook, By Biomedical Devices (2021-2030) ($MN)
Table 69 Europe Biological Machines Market Outlook, By Machine Learning (2021-2030) ($MN)
Table 70 Europe Biological Machines Market Outlook, By Biotechnology (2021-2030) ($MN)
Table 71 Europe Biological Machines Market Outlook, By Artificial Intelligence (2021-2030) ($MN)
Table 72 Europe Biological Machines Market Outlook, By Biofuel Production (2021-2030) ($MN)
Table 73 Europe Biological Machines Market Outlook, By Nanotechnology (2021-2030) ($MN)
Table 74 Europe Biological Machines Market Outlook, By Robotics (2021-2030) ($MN)
Table 75 Europe Biological Machines Market Outlook, By Other Applications (2021-2030) ($MN)
Table 76 Asia Pacific Biological Machines Market Outlook, By Country (2021-2030) ($MN)
Table 77 Asia Pacific Biological Machines Market Outlook, By Type (2021-2030) ($MN)
Table 78 Asia Pacific Biological Machines Market Outlook, By Myosin (2021-2030) ($MN)
Table 79 Asia Pacific Biological Machines Market Outlook, By Dynein (2021-2030) ($MN)
Table 80 Asia Pacific Biological Machines Market Outlook, By Kinesin (2021-2030) ($MN)
Table 81 Asia Pacific Biological Machines Market Outlook, By Ribosomes (2021-2030) ($MN)
Table 82 Asia Pacific Biological Machines Market Outlook, By Other Types (2021-2030) ($MN)
Table 83 Asia Pacific Biological Machines Market Outlook, By Motor Type (2021-2030) ($MN)
Table 84 Asia Pacific Biological Machines Market Outlook, By Linear (2021-2030) ($MN)
Table 85 Asia Pacific Biological Machines Market Outlook, By Flagella Movement (2021-2030) ($MN)
Table 86 Asia Pacific Biological Machines Market Outlook, By Muscle Contraction (2021-2030) ($MN)
Table 87 Asia Pacific Biological Machines Market Outlook, By Rotary (2021-2030) ($MN)
Table 88 Asia Pacific Biological Machines Market Outlook, By Adenosine Triphosphate(ATP) Hydrolysis (2021-2030) ($MN)
Table 89 Asia Pacific Biological Machines Market Outlook, By Bacterial Flagellar (2021-2030) ($MN)
Table 90 Asia Pacific Biological Machines Market Outlook, By Deoxyribonucleic Acid (DNA) Helicases (2021-2030) ($MN)
Table 91 Asia Pacific Biological Machines Market Outlook, By Other Motor Types (2021-2030) ($MN)
Table 92 Asia Pacific Biological Machines Market Outlook, By Application (2021-2030) ($MN)
Table 93 Asia Pacific Biological Machines Market Outlook, By Biomedical Devices (2021-2030) ($MN)
Table 94 Asia Pacific Biological Machines Market Outlook, By Machine Learning (2021-2030) ($MN)
Table 95 Asia Pacific Biological Machines Market Outlook, By Biotechnology (2021-2030) ($MN)
Table 96 Asia Pacific Biological Machines Market Outlook, By Artificial Intelligence (2021-2030) ($MN)
Table 97 Asia Pacific Biological Machines Market Outlook, By Biofuel Production (2021-2030) ($MN)
Table 98 Asia Pacific Biological Machines Market Outlook, By Nanotechnology (2021-2030) ($MN)
Table 99 Asia Pacific Biological Machines Market Outlook, By Robotics (2021-2030) ($MN)
Table 100 Asia Pacific Biological Machines Market Outlook, By Other Applications (2021-2030) ($MN)
Table 101 South America Biological Machines Market Outlook, By Country (2021-2030) ($MN)
Table 102 South America Biological Machines Market Outlook, By Type (2021-2030) ($MN)
Table 103 South America Biological Machines Market Outlook, By Myosin (2021-2030) ($MN)
Table 104 South America Biological Machines Market Outlook, By Dynein (2021-2030) ($MN)
Table 105 South America Biological Machines Market Outlook, By Kinesin (2021-2030) ($MN)
Table 106 South America Biological Machines Market Outlook, By Ribosomes (2021-2030) ($MN)
Table 107 South America Biological Machines Market Outlook, By Other Types (2021-2030) ($MN)
Table 108 South America Biological Machines Market Outlook, By Motor Type (2021-2030) ($MN)
Table 109 South America Biological Machines Market Outlook, By Linear (2021-2030) ($MN)
Table 110 South America Biological Machines Market Outlook, By Flagella Movement (2021-2030) ($MN)
Table 111 South America Biological Machines Market Outlook, By Muscle Contraction (2021-2030) ($MN)
Table 112 South America Biological Machines Market Outlook, By Rotary (2021-2030) ($MN)
Table 113 South America Biological Machines Market Outlook, By Adenosine Triphosphate(ATP) Hydrolysis (2021-2030) ($MN)
Table 114 South America Biological Machines Market Outlook, By Bacterial Flagellar (2021-2030) ($MN)
Table 115 South America Biological Machines Market Outlook, By Deoxyribonucleic Acid (DNA) Helicases (2021-2030) ($MN)
Table 116 South America Biological Machines Market Outlook, By Other Motor Types (2021-2030) ($MN)
Table 117 South America Biological Machines Market Outlook, By Application (2021-2030) ($MN)
Table 118 South America Biological Machines Market Outlook, By Biomedical Devices (2021-2030) ($MN)
Table 119 South America Biological Machines Market Outlook, By Machine Learning (2021-2030) ($MN)
Table 120 South America Biological Machines Market Outlook, By Biotechnology (2021-2030) ($MN)
Table 121 South America Biological Machines Market Outlook, By Artificial Intelligence (2021-2030) ($MN)
Table 122 South America Biological Machines Market Outlook, By Biofuel Production (2021-2030) ($MN)
Table 123 South America Biological Machines Market Outlook, By Nanotechnology (2021-2030) ($MN)
Table 124 South America Biological Machines Market Outlook, By Robotics (2021-2030) ($MN)
Table 125 South America Biological Machines Market Outlook, By Other Applications (2021-2030) ($MN)
Table 126 Middle East & Africa Biological Machines Market Outlook, By Country (2021-2030) ($MN)
Table 127 Middle East & Africa Biological Machines Market Outlook, By Type (2021-2030) ($MN)
Table 128 Middle East & Africa Biological Machines Market Outlook, By Myosin (2021-2030) ($MN)
Table 129 Middle East & Africa Biological Machines Market Outlook, By Dynein (2021-2030) ($MN)
Table 130 Middle East & Africa Biological Machines Market Outlook, By Kinesin (2021-2030) ($MN)
Table 131 Middle East & Africa Biological Machines Market Outlook, By Ribosomes (2021-2030) ($MN)
Table 132 Middle East & Africa Biological Machines Market Outlook, By Other Types (2021-2030) ($MN)
Table 133 Middle East & Africa Biological Machines Market Outlook, By Motor Type (2021-2030) ($MN)
Table 134 Middle East & Africa Biological Machines Market Outlook, By Linear (2021-2030) ($MN)
Table 135 Middle East & Africa Biological Machines Market Outlook, By Flagella Movement (2021-2030) ($MN)
Table 136 Middle East & Africa Biological Machines Market Outlook, By Muscle Contraction (2021-2030) ($MN)
Table 137 Middle East & Africa Biological Machines Market Outlook, By Rotary (2021-2030) ($MN)
Table 138 Middle East & Africa Biological Machines Market Outlook, By Adenosine Triphosphate(ATP) Hydrolysis (2021-2030) ($MN)
Table 139 Middle East & Africa Biological Machines Market Outlook, By Bacterial Flagellar (2021-2030) ($MN)
Table 140 Middle East & Africa Biological Machines Market Outlook, By Deoxyribonucleic Acid (DNA) Helicases (2021-2030) ($MN)
Table 141 Middle East & Africa Biological Machines Market Outlook, By Other Motor Types (2021-2030) ($MN)
Table 142 Middle East & Africa Biological Machines Market Outlook, By Application (2021-2030) ($MN)
Table 143 Middle East & Africa Biological Machines Market Outlook, By Biomedical Devices (2021-2030) ($MN)
Table 144 Middle East & Africa Biological Machines Market Outlook, By Machine Learning (2021-2030) ($MN)
Table 145 Middle East & Africa Biological Machines Market Outlook, By Biotechnology (2021-2030) ($MN)
Table 146 Middle East & Africa Biological Machines Market Outlook, By Artificial Intelligence (2021-2030) ($MN)
Table 147 Middle East & Africa Biological Machines Market Outlook, By Biofuel Production (2021-2030) ($MN)
Table 148 Middle East & Africa Biological Machines Market Outlook, By Nanotechnology (2021-2030) ($MN)
Table 149 Middle East & Africa Biological Machines Market Outlook, By Robotics (2021-2030) ($MN)
Table 150 Middle East & Africa Biological Machines Market Outlook, By Other Applications (2021-2030) ($MN)

Product Code: SMRC24093

According to Stratistics MRC, the Global Biological Machines Market is accounted for $4.6 billion in 2023 and is expected to reach $45.3 billion by 2030 growing at a CAGR of 38.4% during the forecast period. Biological machines, also known bio-machines, are sophisticated systems or gadgets that get their design inspiration from or are made of biological elements like cells, proteins, or genetic material. They are intended to carry out certain jobs or functions. These devices are often designed to replicate or use the capacities of living things for a variety of uses, including as industrial, scientific, and medical ones. These devices have the power to transform a number of sectors and advance our knowledge of biology and technology.

Market Dynamics:

Driver:

Integration with existing biological systems

It is possible to create biological devices that smoothly work with current biological functions. They utilize the accuracy and effectiveness of organic biological processes. They are used to administer medications or carry out duties more precisely by focusing on certain cells or tissues in the human body. Biological and synthetic components can be combined to create hybrid devices with improved or novel functionality. These could be more effective biosensors, bio actuators, or biofuel cells than completely synthetic substitutes. These are the elements driving the market's expansion.

Restraint:

Limited control and predictability

Biological systems are naturally complicated and changeable. The behavior of biological machines can be difficult to anticipate and control since it depends on a wide range of variables, such as genetics, environment, and cellular reactions. Furthermore, biological components might deteriorate over time and have a finite lifetime. This restricts biological machines' long-term usefulness and dependability in comparison to conventional mechanical systems, which is limiting market expansion.

Opportunity:

Reduced waste

When compared to conventional industrial methods, biological systems often generate less waste and hazardous byproducts, making them more ecologically friendly. In order to create a variety of goods, including medicines, biofuels, chemicals, and more, these biological machines frequently employ living organisms like bacteria, yeast, or algae. They generate less waste since they are very effective at turning raw materials into the intended product. This may result in lower waste disposal costs and cleaner production methods. This is the element impacting the market's expansion.

Threat:

Safety and containment

Biological machinery is dangerous in terms of containment and safety. There is a chance that genetically modified organisms will be accidentally released, which might have unforeseen ecological effects. Additionally, it's possible that these devices aren't always as energy-efficient as intended. Although biological systems are naturally energy-efficient at the cellular level, the energy needs for maintaining and managing these components when they are incorporated into machines can be substantial. These are the elements preventing further market expansion.

COVID-19 Impact:

Following COVID-19, strict rules were put in place for logistics, and trade channels were shut down. Transporting products from one location to another was hampered by regulations on the supply chain and logistics sector. Sales of local mead, however, increased as a result of the absence of imported goods brought on by travel bans and border closures during the epidemic. Additionally, because pubs and restaurants were closed for extended periods of time, customers were compelled to change their drinking habits. This trend is anticipated to continue because popular drinks like canned wine.

The myosin segment is expected to be the largest during the forecast period

The myosin segment is expected to be the largest during the forecast period. A protein called myosin is essential for many biological functions, including muscle contraction. The term "biological machines" used to describe the myosin-driven molecular motors has multiple benefits. By utilizing chemical energy (ATP) to produce mechanical power and movement, it functions as a molecular motor. Actin filaments move past one another as it "walks" along them, triggering muscle contraction and a number of other cellular functions.

The machine learning segment is expected to have the highest CAGR during the forecast period

The machine learning segment is expected to have the highest CAGR during the forecast period. Biohybrid systems, commonly referred to as biological machines, provide various benefits when using machine learning. These systems mix artificial elements like sensors or controls with biological elements like cells or organisms to provide flexible and adaptable systems. These systems react dynamically to a variety of stimuli thanks to these algorithms' ability to adapt to changing environmental circumstances or needs.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. There are several biotechnology businesses in this region that strive to create biological machines for a range of uses, including genetic engineering, cell therapy, and drug discovery. The region's universities and research facilities carry out cutting-edge studies in fields relating to biological machines. To progress the field, they frequently work together with business partners and governmental organizations.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. Synthetic biology research has been active throughout the region's nations. In this discipline, biological systems, devices, and components are designed and built for a variety of uses, including the generation of biofuel, medicines, and environmental cleanup. The creation of biological devices for use in medicine is a worldwide endeavor. This covers tissue engineering, the production of artificial organs, and the creation of bioactive materials for medical equipment.

Key players in the market:

Some of the key players in Biological Machines market include: Ginkgo Bioworks, Zymergen, Synthace, Codexis, Twist Bioscience, Evonetix, Arzeda, Synthorx, Amyris, Novozymes, Desktop Genetics, Synlogic and Molecular Machines & Industries.

Key Developments:

In November 2022, Novozymes, the world leader in biological solutions, and LinusBio (Linus Biotechnology Inc.), a leader in precision exposome sequencing, announced the companies are forming a collaboration to test a new, non-invasive technology in a clinical trial.

In October 2022, Ginkgo Bioworks and Zymergen announced that Ginkgo has completed its previously announced acquisition of Zymergen. The acquisition is expected to significantly enhance Ginkgo's platform by integrating strong automation and software capabilities as well as a wealth of experience across diverse biological engineering approaches.

Types Covered:

Myosin
Dynein
Kinesin
Ribosomes
Other Types

Motor Types Covered:

Linear
Rotary
Other Motor Types

Applications Covered:

Biomedical Devices
Machine Learning
Biotechnology
Artificial Intelligence
Biofuel Production
Nanotechnology
Robotics
Other Applications

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Biological Machines Market, By Type

5.1 Introduction
5.2 Myosin
5.3 Dynein
5.4 Kinesin
5.5 Ribosomes
5.6 Other Types

6 Global Biological Machines Market, By Motor Type

6.1 Introduction
6.2 Linear
- 6.2.1 Flagella Movement
- 6.2.2 Muscle Contraction
6.3 Rotary
- 6.3.1 Adenosine Triphosphate(ATP) Hydrolysis
- 6.3.2 Bacterial Flagellar
- 6.3.3 Deoxyribonucleic Acid (DNA) Helicases
6.4 Other Motor Types

7 Global Biological Machines Market, By Application

7.1 Introduction
7.2 Biomedical Devices
7.3 Machine Learning
7.4 Biotechnology
7.5 Artificial Intelligence
7.6 Biofuel Production
7.7 Nanotechnology
7.8 Robotics
7.9 Other Applications

8 Global Biological Machines Market, By Geography

8.1 Introduction
8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa

9 Key Developments

9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling

10.1 Ginkgo Bioworks
10.2 Zymergen
10.3 Synthace
10.4 Codexis
10.5 Twist Bioscience
10.6 Evonetix
10.7 Arzeda
10.8 Synthorx
10.9 Amyris
10.10 Novozymes
10.11 Desktop Genetics
10.12 Synlogic
10.1 Molecular Machines & Industries